118.23
price up icon0.19%   0.22
after-market Handel nachbörslich: 118.23
loading
Schlusskurs vom Vortag:
$118.01
Offen:
$118.51
24-Stunden-Volumen:
548.44K
Relative Volume:
0.60
Marktkapitalisierung:
$7.15B
Einnahmen:
$3.99B
Nettoeinkommen (Verlust:
$463.16M
KGV:
16.65
EPS:
7.1
Netto-Cashflow:
$1.10B
1W Leistung:
+4.75%
1M Leistung:
+10.37%
6M Leistung:
-3.12%
1J Leistung:
+7.93%
1-Tages-Spanne:
Value
$116.65
$118.72
1-Wochen-Bereich:
Value
$111.20
$119.48
52-Wochen-Spanne:
Value
$95.49
$148.06

Jazz Pharmaceuticals Plc Stock (JAZZ) Company Profile

Name
Firmenname
Jazz Pharmaceuticals Plc
Name
Telefon
353-1-634-7800
Name
Adresse
FIFTH FLOOR, WATERLOO EXCHANGE, DUBLIN
Name
Mitarbeiter
2,800
Name
Twitter
@jazzpharma
Name
Nächster Verdiensttermin
2024-11-06
Name
Neueste SEC-Einreichungen
Name
JAZZ's Discussions on Twitter

Vergleichen Sie JAZZ mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
JAZZ
Jazz Pharmaceuticals Plc
118.23 7.14B 3.99B 463.16M 1.10B 7.10
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
469.65 121.28B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
563.10 60.96B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
328.81 42.77B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
591.99 36.21B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
291.47 32.08B 3.81B -644.79M -669.77M -6.24

Jazz Pharmaceuticals Plc Stock (JAZZ) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-07-15 Eingeleitet Deutsche Bank Buy
2025-03-07 Hochstufung UBS Neutral → Buy
2025-02-26 Herabstufung Cantor Fitzgerald Overweight → Neutral
2025-02-13 Hochstufung Wells Fargo Equal Weight → Overweight
2024-12-12 Hochstufung Morgan Stanley Equal-Weight → Overweight
2024-06-05 Eingeleitet Goldman Buy
2024-01-03 Eingeleitet Robert W. Baird Outperform
2023-11-27 Herabstufung UBS Buy → Neutral
2023-09-29 Eingeleitet Raymond James Mkt Perform
2023-06-12 Fortgesetzt Wells Fargo Equal Weight
2022-12-09 Hochstufung Goldman Neutral → Buy
2022-06-14 Eingeleitet UBS Buy
2022-04-06 Herabstufung Goldman Buy → Neutral
2021-11-19 Fortgesetzt Goldman Buy
2021-10-07 Fortgesetzt Jefferies Buy
2021-10-05 Eingeleitet Citigroup Buy
2021-09-23 Eingeleitet Needham Buy
2021-05-19 Fortgesetzt JP Morgan Overweight
2021-04-07 Fortgesetzt RBC Capital Mkts Outperform
2021-02-05 Bestätigt H.C. Wainwright Buy
2021-02-03 Hochstufung Piper Sandler Neutral → Overweight
2021-01-29 Herabstufung Morgan Stanley Overweight → Equal-Weight
2020-12-16 Eingeleitet UBS Buy
2020-11-03 Bestätigt H.C. Wainwright Buy
2020-10-09 Bestätigt H.C. Wainwright Buy
2020-09-14 Herabstufung Goldman Neutral → Sell
2020-09-14 Fortgesetzt JP Morgan Overweight
2020-08-06 Hochstufung Morgan Stanley Equal-Weight → Overweight
2020-07-28 Hochstufung Wolfe Research Peer Perform → Outperform
2020-07-23 Hochstufung H.C. Wainwright Neutral → Buy
2020-04-06 Eingeleitet Jefferies Buy
2020-03-12 Hochstufung Bernstein Mkt Perform → Outperform
2020-01-08 Eingeleitet Goldman Neutral
2019-08-21 Herabstufung Piper Jaffray Overweight → Neutral
2019-06-11 Eingeleitet Barclays Overweight
2019-03-20 Eingeleitet SunTrust Buy
2018-12-14 Eingeleitet Wolfe Research Peer Perform
2018-11-08 Bestätigt B. Riley FBR Buy
2018-08-08 Bestätigt Stifel Buy
2018-07-11 Herabstufung Morgan Stanley Overweight → Equal-Weight
2018-03-23 Bestätigt H.C. Wainwright Neutral
2018-03-19 Hochstufung Morgan Stanley Equal-Weight → Overweight
Alle ansehen

Jazz Pharmaceuticals Plc Aktie (JAZZ) Neueste Nachrichten

pulisher
Jul 25, 2025

Is Jazz Pharmaceuticals plc a good long term investmentOverwhelming financial success - PrintWeekIndia

Jul 25, 2025
pulisher
Jul 25, 2025

What analysts say about Jazz Pharmaceuticals plc stockSuperior portfolio returns - PrintWeekIndia

Jul 25, 2025
pulisher
Jul 25, 2025

Idiopathic Hypersomnia Treatment Market Propelled by Rising - openPR.com

Jul 25, 2025
pulisher
Jul 24, 2025

Will Jazz Pharmaceuticals plc stock benefit from AI tech trendsExplosive capital gains - jammulinksnews.com

Jul 24, 2025
pulisher
Jul 23, 2025

Pharma 50: The top pharma companies in the world for 2025 - drugdiscoverytrends.com

Jul 23, 2025
pulisher
Jul 23, 2025

Jazz Pharmaceuticals (JAZZ) Highlights Growth at Goldman Sachs Healthcare Conference - MSN

Jul 23, 2025
pulisher
Jul 23, 2025

What drives Jazz Pharmaceuticals plc stock priceUnmatched market performance - Autocar Professional

Jul 23, 2025
pulisher
Jul 22, 2025

Jazz Pharmaceuticals plc Stock Analysis and ForecastRecord-setting profit potential - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

Jazz Pharmaceuticals to Report Second Quarter Financial Results on August 5, 2025 - 富途牛牛

Jul 22, 2025
pulisher
Jul 21, 2025

Lacklustre Performance Is Driving Jazz Pharmaceuticals plc's (NASDAQ:JAZZ) Low P/E - simplywall.st

Jul 21, 2025
pulisher
Jul 17, 2025

Zymeworks to Report Second Quarter 2025 Financial Results and Host Conference Call on August 7, 2025 - GlobeNewswire Inc.

Jul 17, 2025
pulisher
Jul 15, 2025

Jazz Pharmaceuticals Stock Offers Buying Opportunity After Slump, Deutsche Bank Says - MarketScreener

Jul 15, 2025
pulisher
Jul 15, 2025

Jazz Pharmaceuticals (JAZZ) Receives Buy Rating from Deutsche Ba - GuruFocus

Jul 15, 2025
pulisher
Jul 15, 2025

Deutsche Bank initiates Jazz Pharmaceuticals stock with Buy rating By Investing.com - Investing.com Nigeria

Jul 15, 2025
pulisher
Jul 15, 2025

Deutsche Bank Initiates Jazz Pharmaceuticals at Buy With $152 Price Target - MarketScreener

Jul 15, 2025
pulisher
Jul 14, 2025

What makes Jazz Pharmaceuticals plc stock price move sharplyFree Capital Allocation Plans - beatles.ru

Jul 14, 2025
pulisher
Jul 14, 2025

Ireland: Renee Gala elected CEO at Jazz Pharma - Investors in Healthcare

Jul 14, 2025
pulisher
Jul 11, 2025

Jazz names new CEO; Ultragenyx, Mereo shares slide on trial update - BioPharma Dive

Jul 11, 2025
pulisher
Jul 11, 2025

Jazz Pharmaceuticals Appoints Renee Gala as New CEO - The Globe and Mail

Jul 11, 2025
pulisher
Jul 11, 2025

Jazz Pharmaceuticals names Renee Gala as next CEO By Investing.com - Investing.com South Africa

Jul 11, 2025
pulisher
Jul 11, 2025

Innoviva, Inc. shares rise 2.05% premarket after Jazz Pharmaceuticals announces CEO succession plan. - AInvest

Jul 11, 2025
pulisher
Jul 11, 2025

Jazz Pharmaceuticals names Renee Gala as next CEO - Investing.com Australia

Jul 11, 2025
pulisher
Jul 11, 2025

1 Profitable Stock with Solid Fundamentals and 2 to Brush Off - Yahoo Finance

Jul 11, 2025

Finanzdaten der Jazz Pharmaceuticals Plc-Aktie (JAZZ)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$23.40
price down icon 0.97%
$36.67
price up icon 0.22%
$103.95
price up icon 0.42%
$28.67
price up icon 3.99%
$115.31
price up icon 0.65%
biotechnology ONC
$291.47
price down icon 1.68%
Kapitalisierung:     |  Volumen (24h):